However, to our knowledge, there has been limited investigation into the TRPS1 immunoreactivity status in cutaneous mesenchymal tumors and tumors of uncertain differentiation, such as AFXs or PDSs. Here, TRPS1 is linked to mesenchymal cell neoplasm.